Gesundheit
By Andrii Holovko
8 min read

Introduction: What is the flu, and what does the 2025/2026 flu season mean?

Influenza, commonly known as the flu, is an acute viral infection of the upper and lower respiratory tract. It is caused by influenza viruses of types A, B and, rarely, C. Unlike a common cold (usually caused by rhinoviruses, coronaviruses or other pathogens), the flu often follows a more severe, systemic course. Typical symptoms appear suddenly: high fever (38.5–40 °C), chills, severe headaches and body aches, a dry cough, sore throat, extreme fatigue and muscle pain, which can last for days to weeks. Complications such as bacterial superinfections (pneumonia), myocarditis, encephalitis or exacerbations of chronic conditions (asthma, COPD, diabetes) are particularly common in at-risk groups: adults aged 60 and over, children under 5, pregnant people, immunocompromised people and people with pre-existing conditions. Transmission occurs primarily through droplets and aerosols when coughing, sneezing or speaking, but also via the fecal-oral route or contaminated surfaces (contact transmission). The incubation period is 1–4 days, and people are contagious for 5–7 days (longer if immunocompromised). The flu is highly contagious: on average, one person infects 1.3–1.8 others (reproduction number R0). Flu season – or the season for acute respiratory infections (ARIs) – runs from October to April in the Northern Hemisphere. During this period, incidence rises seasonally, as cold weather, dry air and crowded indoor spaces favor viral transmission. Alongside influenza, RSV, SARS-CoV-2, rhinoviruses, parainfluenza viruses, adenoviruses and hMPV are circulating – often simultaneously in a “tripledemic” (flu + RSV + COVID-19). The 2025/2026 season is exceptional: it began 3–4 weeks earlier than usual (from week 48/2025), driven by a highly mutated variant of the influenza A virus: A(H3N2) subclade K (also known as J.2.4.1). This subclade has spread rapidly since August 2025, as it differs substantially from earlier strains antigenically and evades population immunity. Experts describe it as a “perfect storm”: an early start, greater severity among older adults and low vaccination rates in some countries. According to the World Health Organization (WHO) – Influenza Global Situation, A(H3N2) subclade K is dominant worldwide, with high activity in Europe, North America and Asia. In Europe, the season is more intense than in 2024/2025, with earlier peaks and increased hospitalizations. Why does this matter? Every year, 5–20% of the EU population gets influenza, causing 7–12,000 deaths in Europe alone. The economic costs amount to billions due to missed work and treatment. In Germany alone, more than 80,000 laboratory-confirmed cases had been reported by mid-January in the 2025/2026 season, with 225 deaths (mostly among people >65 years). This article examines the current pathogens, official data, evidence-based prevention and steps to take when ill – based on the latest reports from the Robert Koch Institute (RKI) – Influenza Surveillance and the European Centre for Disease Prevention and Control (ECDC) – Weekly Respiratory Virus Update. The aim is to provide you with reliable information and encourage you to take action. Let’s move seamlessly on to current cases to paint a clear picture of the situation.

Current respiratory illnesses in 2026: viruses, symptoms and risks

The 2025/2026 flu season shows a clear dominance: the influenza A virus, specifically subtype A(H3N2) subclade K, accounts for up to 90% of flu cases. This variant has been widespread since fall 2025 and causes typical symptoms: sudden high fever, severe cough, muscle aches and pronounced fatigue. Older adults and people with pre-existing conditions are at particular risk of severe illness, such as pneumonia. RSV (respiratory syncytial virus) is also circulating widely, especially among babies and toddlers (bronchiolitis) and older adults (pneumonia). Symptoms: wheezing, cough and shortness of breath. In week 3/2026, RSV activity is high but no longer increasing (ECDC). SARS-CoV-2 (COVID-19) remains at a low level: positivity rate below 10%, situation stable. Symptoms are similar to flu, often with loss of smell or taste and a risk of long COVID. Other common pathogens:
  • Rhinoviruses (approx. 25–30% of respiratory infections): Mild runny nose, sore throat, sneezing - often in schools and kindergartens.
  • Human metapneumovirus (hMPV): Cough and fever, similar to RSV.
  • Parainfluenza viruses (types 1–4): Croup in children.
  • Adenoviruses: In addition to respiratory symptoms, they can also cause conjunctivitis or gastrointestinal problems.
The “tripledemic” (flu + RSV + COVID-19) is putting a heavy strain on the healthcare system. Compared with the 2024/2025 season: earlier start, higher incidence (positivity rate 25–39%) and more hospital admissions (+20–30%). Risk factors include age, pre-existing conditions and low vaccination rates.
Overview of pathogens in 2025/2026
Pathogen Share (%) Key symptoms Affected groups Current status (Jan 2026)
Influenza A(H3N2) subclade K ~90 High fever, cough, muscle aches Older adults, children High, peak partly exceeded
RSV Medium Wheezing, cough, shortness of breath Babies, older adults High, stable
SARS-CoV-2 Low Fever, cough, fatigue Everyone Low, stable
Rhinoviruses 25–30 Runny nose, sneezing Children Common
This overview helps explain the threat - now let's look at the hard numbers to get a clearer picture of the situation.

Official statistics on flu and respiratory illnesses in Germany, the EU and UK

As of mid-January 2026 (based on RKI, ECDC, UKHSA and WHO):
  • Germany (RKI): More than 80,000 laboratory-confirmed flu cases since the start of the season. Incidence was high in weeks 1–3/2026. Hospitalizations are up 20–30% compared with 2024/2025. Deaths: approximately 225 (mainly people over 65). RSV and COVID-19 are also contributing: RSV elevated, COVID low. All notifiable diseases, including influenza, are listed in the RKI’s overview table of notifiable diseases and pathogens.
  • EU/EEA (ECDC): Influenza activity is high, but the peak appears to have passed in most countries (week 3/2026). Positivity 25–39%. A(H3N2) dominant. RSV high, COVID low. 7–12,000 flu deaths annually.
  • UK (UKHSA): Flu activity is declining in week 3/2026 (January 15), but remains at a moderate level. Positivity rates and hospitalizations are falling, but are higher than last year. RSV and COVID-19 remain low and stable. Data from the National Flu and COVID-19 Surveillance Report Week 3 2026 show a decline, but continued pressure on hospitals. Influenza positivity: 11.7–11.9% (through January 11), down from 14.1% the previous week. Hospitalization rate: falling to ~5.37 per 100,000 people.
These figures underscore the seriousness of the situation – but fortunately, there are effective ways to protect yourself. Let’s move on to prevention strategies.
Key figures (Jan 2026)
Region Flu cases/incidence Hospitalizations Deaths RSV/COVID status
Germany >80,000 cases +20–30% ~225 RSV high, COVID low
EU/EEA Positivity 25–39% +20% 7–12k/year Peak passed, RSV high
UK Falling (week 3, 11.7–11.9% positivity) Declining (~5.37/100,000) Moderate RSV stable, COVID low
Prevention: The best way to fight flu and colds

Prevention: The best way to fight flu and colds

Prevention is the most effective protection – it reduces the risk of illness by up to 60% and lessens the severity of severe cases. These measures are based on recommendations from the RKI, ECDC, and WHO. By implementing them step by step, we can make the season safer.

Vaccination – the most important pillar: Annual flu vaccination protects against severe illness (VE 40–60%, around 41% against A(H3N2) subclade K). It is particularly recommended for at-risk groups (older adults, children, pregnant people, and people with chronic illnesses). More than 18 million doses are available in Germany – get vaccinated! Studies show that vaccinated people are less likely to be hospitalized.

Hygiene and everyday habits: Washing your hands regularly (for at least 20 seconds with soap) reduces transmission by 16–21% (Cochrane review). Sneeze or blow your nose into your elbow, keep your distance (at least 1.5 m), and air out rooms several times a day. Wear an FFP2 mask in crowds or when near people who are ill. These simple habits can halve infections.

Disinfection: Regularly cleaning surfaces (door handles, handrails) and disinfecting your hands minimizes the spread of infection via contaminated surfaces. Virucidal products are ideal for this, as they reliably kill viruses. For thorough disinfection of surfaces at home or in the office, choose proven products from our range: surface disinfectant. Practical for everyday use: hand sanitizer, which works quickly and is gentle on the skin.

Lifestyle: A balanced diet (plenty of fruit and vegetables, vitamin D), regular exercise, enough sleep, and stress reduction strengthen the immune system. Avoid crowds during peak season. Combine these tips to build a strong barrier.

This combination of vaccination, hygiene, and disinfection offers the best protection - easy to put into practice and highly effective. If you do become ill, acting quickly is crucial - find out more in the next section.

2025/2026 flu season: What should you do if you are already sick?

What should you do if you are already sick?

Take action immediately at the first symptoms (fever, cough, body aches): stay home to avoid infecting others. Drink plenty of fluids (tea, water, soup), get some rest, and avoid physical exertion. Proven remedies such as paracetamol or ibuprofen can help with fever and pain (follow the package instructions for dosage). If you suspect the flu, a doctor can prescribe oseltamivir (Tamiflu) within the first 48 hours - it is particularly effective for high-risk patients (RKI recommendation). When started early, this antiviral shortens the illness and reduces complications.

When should you see a doctor? Seek immediate medical attention for: a fever over 39 °C lasting more than 3 days, severe shortness of breath, chest pain, confusion, persistent vomiting, or if you belong to a high-risk group. For children: Go to the emergency room immediately if they breathe rapidly, have blue lips, or are lethargic. Early diagnosis with a rapid test can help determine the right treatment.

At home, you can help with saline inhalations (for coughs), humid air (using a humidifier), and honey tea (for coughs in children aged 1 and over). Make sure to get enough sleep and eat light meals. For long-term immune support, we recommend our article: Flu and cold season: Tips for a strong immune system – with nutrition tips, vitamins, and lifestyle changes. This will help you recover faster and avoid secondary infections.

Conclusion

The 2025/2026 flu season presents challenges – with an early and intense course driven by A(H3N2) subclade K, high case numbers in Germany, the EU, and the UK, as well as the burden of RSV and COVID-19. But the good news is that we have proven tools at our disposal to protect ourselves and our loved ones effectively. Vaccination, consistent hygiene, and disinfection dramatically reduce the risk and lessen the severity of illness. Many people get through the season with no symptoms or only mild ones thanks to these measures. By staying informed and taking action, we can minimize the impact.

Use the latest data from RKI, ECDC, and UKHSA to stay informed – the peak has passed in many regions, but caution is still needed. Every vaccinated person, every disinfected handle, and every ventilated room helps slow the spread and ease the burden on the healthcare system. It’s never too late to take action: get vaccinated, follow hygiene rules, and turn to proven products when needed. Remember: prevention is not just protection, but also freedom – for a carefree winter.

In the end, it’s about more than just health – it’s about quality of life, family, and everyday life without fear. With knowledge and the right steps, we can get through this season and emerge stronger. Stay healthy and optimistic!


About Andrii Holovko

Andrii Holovko is an analyst with a university education in computer science, library science, and pedagogy. Thanks to his experience in public relations (PR) and many years of work in the IT industry, he writes expert articles on current topics, based on in-depth analyses and up-to-date scientific sources. His current professional focus is on creating high-quality content (content creation) and online marketing.